Skip to main content
VaccineWatch
VaccinesSymptomsStatesAnalysisToolsDashboardCompare

VaccineWatch

Transparent access to VAERS data for informed decision-making. We present the data as-is, with appropriate context and disclaimers.

Explore Data

  • Vaccines
  • Symptoms
  • Manufacturers
  • States
  • Dashboard
  • Compare Tool
  • Search

Deep Dives

  • The Denominator Problem
  • Onset Timing
  • Lot Number Analysis
  • COVID Impact
  • Myocarditis
  • Death Reports
  • Interactive Tools
  • All 23 Articles →

Resources

  • About
  • Methodology
  • FAQ
  • Glossary
  • Side Effects Guide
  • Vaccine Schedule
  • Vaccine Safety
  • Safety Timeline
  • Adverse Events
  • Is VAERS Reliable?
  • Report an Event
  • Disclaimer
  • VAERS Official Site ↗

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending
  • OpenMedicare
  • OpenLobby
  • TheDataProject.ai

Data source: VAERS (Vaccine Adverse Event Reporting System)

Data through 2026 · Updated quarterly

Built by TheDataProject.ai · © 2026 VaccineWatch

Important: VAERS accepts reports of adverse events following vaccination. For any given report, there is no certainty that the reported event was caused by the vaccine. Reports may contain information that is incomplete, inaccurate, coincidental, or unverifiable. Most reports to VAERS are voluntary, which means they are subject to biases. This data cannot be used to determine if vaccines cause or contribute to adverse events.

⚠️

Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.

  1. Home
  2. Analysis
  3. Pediatric VAERS Analysis
6 min read
Share

Pediatric VAERS Reports

Children ages 0-17 represent a unique population in VAERS reporting. With distinct vaccination schedules and physiology, their adverse event profiles differ from adults.

381,262
pediatric reports (0-17) — 19.2% of all VAERS reports

The Pediatric Landscape

Children ages 0-17 account for 381,262 VAERS reports, representing 19.2% of the total. The youngest group (0-2) has 149,466 reports, while children 3-17 account for 231,796.

Notably, infants (0-2) have a disproportionately high number of death reports (3,406) relative to their total reports. This reflects the tragic reality of Sudden Infant Death Syndrome (SIDS) and other conditions that can occur in infancy, some of which may be temporally associated with routine vaccination without being caused by it.

Childhood Vaccination Schedule

The CDC recommends a standard childhood vaccination schedule that covers dozens of doses in the first few years of life. Vaccines like DTaP, MMR, varicella, and pneumococcal are routinely administered. Because so many doses are given to young children, a significant portion of VAERS reports naturally come from this age group.

Outcome Severity

Among pediatric reports, 3,892 mentioned death and 24,488 involved hospitalization. The death rate among 0-2 year old reports (2.3%) is notably higher than for 3-17 year olds (0.2%), again reflecting SIDS and neonatal conditions.

Key Takeaways

  • 1.Children 0-17 account for 19.2% of all VAERS reports
  • 2.Infants (0-2) have higher death report rates, largely reflecting SIDS and neonatal conditions
  • 3.The intensive childhood vaccination schedule means more temporal associations with common conditions
  • 4.VAERS reports alone cannot establish that vaccines caused any observed adverse event

Related Analysis

Age Patterns in VAERS
Full age group analysis
Serious Outcomes Analysis
Severity across all demographics